NOVEL ANTI-HLA-A2 ANTIBODIES AND USES THEREOF
- Sangamo Therapeutics France
- University of British Columbia
The present invention relates to a novel anti-HLA-A2 antibody, and to a chimeric antigen receptor comprising said HLA-A2 antibody. The present invention further relates to an immune cell expressing said chimeric receptor antigen, and to therapeutic uses thereof, in particular for treating or preventing graft rejection or GVHD.